Table 5 presents the clinical outcomes of hepatitis A and hepatitis E patients, including the duration of transaminitis (determined by ALT levels), duration of jaundice, length of hospital stay, incidence of acute liver failure, and mortality rates. This evidence concerns the gene GPT and hepatitis A virus infection.